These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2044166)

  • 1. [Induced abortion using a progesterone antagonist--mifepristone (RU 486)].
    Presl J
    Cesk Gynekol; 1991 Feb; 56(1):56-7. PubMed ID: 2044166
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical presentation of serious pelvic inflammatory disease following mifepristone-induced medical abortion.
    Sparrow M; Shand C; Macdonald J
    Contraception; 2006 Oct; 74(4):352-3; author reply 353-4. PubMed ID: 16982242
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antiprogesterones--new prospects in induced abortion].
    Karag'ozov I; Chernev T
    Akush Ginekol (Sofiia); 1994; 33(2):47-9. PubMed ID: 7485784
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences with the antigestagen mifepristone (RU 486) in the interruption of early pregnancy].
    Carol W; Klinger G
    Zentralbl Gynakol; 1989; 111(19):1325-8. PubMed ID: 2588863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mifepristone-induced abortion and placental complications in subsequent pregnancy.
    Zhu QX; Gao ES; Chen AM; Luo L; Cheng YM; Yuan W
    Hum Reprod; 2009 Feb; 24(2):315-9. PubMed ID: 19054774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical presentation of serious pelvic inflammatory disease following mifepristone-induced medical abortion.
    Lawton BA; Rose SB; Shepherd J
    Contraception; 2006 Apr; 73(4):431-2. PubMed ID: 16531180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ethical controversy surrounding RU 486: data and arguments].
    Reiter-Theil S; Dressel R
    Diskussionsforum Med Ethik; 1992; (6-7):XXXIII-XXXVII. PubMed ID: 1514298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [RU 486: safe and wrongfully maligned].
    von Werder K
    Fortschr Med; 1993 Aug; 111(24):8-9. PubMed ID: 8406282
    [No Abstract]   [Full Text] [Related]  

  • 9. Clostridium sordellii toxic shock syndrome after medical abortion with mifepristone and intravaginal misoprostol--United States and Canada, 2001-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Jul; 54(29):724. PubMed ID: 16049422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deaths from Clostridium sordellii after medical abortion.
    Sicard D
    N Engl J Med; 2006 Apr; 354(15):1645-7; author reply 1645-7. PubMed ID: 16615188
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombotic thrombocytopenic purpura secondary to mifepristone in a patient of medical termination in early pregnancy.
    Chung LW; Yeh SP; Hsieh CY; Chiu CF
    Ann Hematol; 2007 May; 86(5):385-6. PubMed ID: 17180387
    [No Abstract]   [Full Text] [Related]  

  • 12. Möbius syndrome in a neonate after mifepristone and misoprostol elective abortion failure.
    Bos-Thompson MA; Hillaire-Buys D; Roux C; Faillie JL; Amram D
    Ann Pharmacother; 2008 Jun; 42(6):888-92. PubMed ID: 18460590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal expression of MMP-9 and imbalance of MMP-9/TIMP-1 is associated with prolonged uterine bleeding after a medical abortion with mifepristone and misoprostol.
    Li L; Zhou Z; Huang L
    Acta Obstet Gynecol Scand; 2009; 88(6):673-9. PubMed ID: 19353331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approval of mifepristone (RU 486) in Europe.
    Sitruk-Ware R
    Zentralbl Gynakol; 2000; 122(5):241-7. PubMed ID: 10857210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late second-trimester abortions induced with mifepristone, misoprostol and oxytocin: a report of 428 consecutive cases.
    Esteve JL; Gallego FG; Llorente MP; Bermúdez SB; Sala ES; González LV; Texidó CS
    Contraception; 2008 Jul; 78(1):52-60. PubMed ID: 18555818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral administration of an antiprogesterone (Mifepristone, RU 486) for preparing the cervix uteri for pregnancy interruption during the first trimester].
    De Grandi P; Giudici G
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(6):801-8. PubMed ID: 2689506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium sordellii infection in medical abortion.
    Winikoff B
    Clin Infect Dis; 2006 Dec; 43(11):1447-8. PubMed ID: 17083019
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
    Papp C; Schatz F; Krikun G; Hausknecht V; Lockwood CJ
    Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks of mifepristone abortion in context.
    Crockett SA
    Contraception; 2006 Aug; 74(2):174; author reply 175-6. PubMed ID: 16860057
    [No Abstract]   [Full Text] [Related]  

  • 20. Risks of mifepristone abortion in context.
    Grimes DA
    Contraception; 2006 Aug; 74(2):174-5 author reply175-6. PubMed ID: 16860058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.